info icon

Use of levodopa decarboxylase inhibitor

PDMED_LEVODOPA_DECARBOXYLASEINHIBITOR

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

429209

1. Apply sex-specific rule

None

429209

2. Check conditions

None

429209

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Medicine purchases: ATC N04BA02

1 out of 7 registries used, show all original rules.

4053

4. Check minimum number of events

Min. number of events 3
4053

5. Include endpoints

None

4053

6. Filter based on genotype QC (FinnGen only)

3941

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze DF2

Case counts by codes

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 3941 1583 2358
Unadjusted period prevalence (%) 1.05 0.69 1.30
Median age at first event (years) 70.98 69.88 71.72

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: PDMED_LEVODOPA_DECARBOXYLASEINHIBITOR – Use of levodopa decarboxylase inhibitor

GWS hits: -

loading spinner Loading Relationships table